Press Release

Global Peptide Therapeutics Market revenue expected to reach 28.5 billion US dollars 2017

Date : Nov 13, 2018

In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.

The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.

Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.

With peptides evolving as a potential therapeutic agent for the treatment of cancer, the cancer segment emerged as the key contributor to this market in 2017. The rising mortality rate, caused by cancer, has led to an increased focus of players towards the development of new drugs and products to combat the situation, which is influencing the market substantially. The technological advancements and extensive research and development activities are likely to fuel the uptake of peptide therapeutics for the treatment of cancer over the next few years.

North America is the largest consumption place, with a consumption market share nearly 66.7% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 18.1%, China is also an important sales region for the Peptide Therapeutics.

Market competition is intense. Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.

The rise in research activities and development pipeline of peptide drugs is projected to bring significant growth in this market over the next few years. However, the high complexity of peptides may obstruct the manufacturing of peptide drugs over the forthcoming years, reflecting poorly on the overall progress of the market.

The Global Peptide Therapeutics Sales Market Report 2018 This report released by we provides a basic overview of the Peptide Therapeutics industry, including definition, classification, application and industrial chain structure. Discuss development policies and plans as well as manufacturing processes and cost structures.

The report then focuses on major industry players in Global, including company profiles, product images and specifications, sales, market share, and contact information. More importantly, the Peptide Therapeutics industry development trends and marketing channels were analyzed.Providing the main statistical data on the current status of the industry is a valuable guide and direction for companies and individuals interested in the market.

View Full Report with TOC@

Download Sample of this report@

Would like to place an order or any question, please feel free to contact at  &

Contact No: +13474743864